Posterior cortical hypometabolism measured with 18F-fluorodeoxyglucose (FDG)-PET is a well-known marker of Alzheimer's disease-related neurodegeneration, but its associations with underlying neuropathological processes are unclear. We assessed cross-sectionally the relative contributions of three potential mechanisms causing hypometabolism in the retrosplenial and inferior parietal cortices: local molecular (amyloid and tau) pathology and atrophy, distant factors including contributions from the degenerating medial temporal lobe or molecular pathology in functionally connected regions, and the presence of the apolipoprotein E (APOE) ε4 allele. Two hundred and thirty-two amyloid-positive cognitively impaired patients from two cohorts [Univer...
Positron emission tomography (PET) studies using [18F]2-fluoro-2-deoxyglucose (FDG) have identified ...
The development of tau-specific positron emission tomography (PET) tracers allows imaging in vivo th...
Background: Alzheimer’s disease pathology (AD) is an important cause of neurodegeneration and brain ...
Posterior cortical hypometabolism measured with [ 18 F]-Fluorodeoxyglucose (FDG)-PET is a well-known...
International audienceGray matter atrophy, glucose hypometabolism, and β-amyloid Aβ deposition are w...
In PET studies of patients with Alzheimer disease (AD), prominent hypometabolism can occur in brain ...
Relationship of Tau Deposition and Hypometabolism in Alzheimer’s Disease: A Multimodal Imaging Appro...
In its original form, the amyloid cascade hypothesis of Alzheimer's disease holds that fibrillar dep...
The advent of the positron emission tomography tracer 18 F-AV1451 provides the unique opportunity to...
PurposePosterior cingulate cortex (PCC) hypometabolism as measured by FDG PET is an indicator of Alz...
Determining the relative contribution of amyloid plaques and neurofibrillary tangles to brain dysfun...
Positive cerebrospinal fluid (CSF) biomarkers of tau and amyloid beta42 suggest possible active unde...
We investigated the association between amyloid-β deposition and white matter (WM) integrity as a de...
Aims: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especial...
ObjectiveUsing data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) population, we exami...
Positron emission tomography (PET) studies using [18F]2-fluoro-2-deoxyglucose (FDG) have identified ...
The development of tau-specific positron emission tomography (PET) tracers allows imaging in vivo th...
Background: Alzheimer’s disease pathology (AD) is an important cause of neurodegeneration and brain ...
Posterior cortical hypometabolism measured with [ 18 F]-Fluorodeoxyglucose (FDG)-PET is a well-known...
International audienceGray matter atrophy, glucose hypometabolism, and β-amyloid Aβ deposition are w...
In PET studies of patients with Alzheimer disease (AD), prominent hypometabolism can occur in brain ...
Relationship of Tau Deposition and Hypometabolism in Alzheimer’s Disease: A Multimodal Imaging Appro...
In its original form, the amyloid cascade hypothesis of Alzheimer's disease holds that fibrillar dep...
The advent of the positron emission tomography tracer 18 F-AV1451 provides the unique opportunity to...
PurposePosterior cingulate cortex (PCC) hypometabolism as measured by FDG PET is an indicator of Alz...
Determining the relative contribution of amyloid plaques and neurofibrillary tangles to brain dysfun...
Positive cerebrospinal fluid (CSF) biomarkers of tau and amyloid beta42 suggest possible active unde...
We investigated the association between amyloid-β deposition and white matter (WM) integrity as a de...
Aims: Physiopathological mechanisms of Alzheimer's disease (AD) are still matter of debate. Especial...
ObjectiveUsing data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) population, we exami...
Positron emission tomography (PET) studies using [18F]2-fluoro-2-deoxyglucose (FDG) have identified ...
The development of tau-specific positron emission tomography (PET) tracers allows imaging in vivo th...
Background: Alzheimer’s disease pathology (AD) is an important cause of neurodegeneration and brain ...